Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-21-054492

Director bought 40,000 shares at $15.45 ($618,000)

From the SEC's structured data for this filing

Trades in this filing

William Arsani · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-31 Purchase : show line 1 in the form +40,000 $15.45 $618,000 2,772,501 I
Open-market purchases · 40,000 sh · avg $15.45 · $618,000
Loading xslF345X03/doc4.xml…